Lates News

Guosen Securities research report indicates that the medical aesthetics industry is expected to maintain high single-digit steady growth in the next three years. Structural opportunities in the industry are prominent, including: 1) Some medical aesthetic materials still have a competitive advantage in areas such as natural, recombinant collagen, regenerative microspheres, and materials such as PDRN/ECM/silk protein/PHA that have not yet been certified; 2) Upstream product companies with platform empowerment capabilities; 3) Downstream medical aesthetics terminal institutions with high reputation, integration of upstream resources, and the ability to maintain differentiation through comprehensive solutions.